Cancer screening revolution

CRCbioscreen

This company develops a stool-based diagnostic test to improve colorectal cancer screening for healthcare providers and national screening programmes.

Geneoscopy

The company develops non-invasive, stool-based RNA diagnostic tests for colorectal cancer screening and gastrointestinal disease monitoring for patients and healthcare providers.

Guardant

The company develops blood-based liquid biopsy tests for cancer screening and monitoring for patients and healthcare providers.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

Grail

This company develops multi-cancer early detection blood tests for asymptomatic adults at elevated risk and healthcare systems to identify cancer signals across many types.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Freenome

This company develops blood-based screening tests to detect cancer early for patients, healthcare providers, and biopharmaceutical partners.

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.